Detailseite
Projekt Druckansicht

RESPONDER Studie - Diagnose einer pathologischen Komplettremission durch eine Vakuum-assistierte Biopsie nach neoadjuvanter Chemotherapie bei Mammakarzinom

Antragsteller Professor Dr. Jörg Heil
Fachliche Zuordnung Gynäkologie und Geburtshilfe
Hämatologie, Onkologie
Förderung Förderung von 2016 bis 2019
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 286676905
 
Chemotherapy before surgery (=neoadjuvant chemotherapy, NAGT) is increasingly used in breast cancer treatment. Moreover, a pathological complete response in the breast (pCR-B = no tumor cells survived NAGT) is achieved with growing frequency. This scenario provokes the widely debated issue whether local treatment (surgery and / or radiotherapy) is actually beneficial in patients experiencing a pCR-B. Any type of breast cancer surgery as weil as radiotherapy is associated with the risk of physical and psychological morbidity. Should these procedures prove not to serve any therapeutic purpose, patients deserve to be spared its' negative effects.However, before this question regarding the therapeutic benefit of local treatment can be investigated, it is essential to prove that a reliable diagnosis of pCR-B is possible without surgery. Nowadays, a pCR-B can only be confirmed by the histopathologic evaluation of the surgical specimen; imaging methods as ultrasound, mammography or MRI do not provide a valid prediction.This proposed multicenter, confirmative, clinical trial aims to confirm that a pCR-B can be validly diagnosed by using vacuum-assisted, minimal invasive biopsy techniques (VAB). Within this study the VAB will be performed after NAGT and before standard surgical treatment which will be carried out in every patient. We will include 600 patients with at least partial response in ultrasound and/or mammography and/or MRI. The aim of the study is to confirm that less than 10% of the patients with a residual tumor after NAGT are falsely classified as having no residual tumor by the VAB.
DFG-Verfahren Klinische Studien
 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung